About PeptideQuill
Independent peptide industry coverage
PeptideQuill covers the research peptide industry with independent analysis, evidence-based compound reviews, and regulatory reporting. We exist because the peptide space has a credibility problem — and researchers deserve better than vendor marketing dressed up as journalism.
What We Cover
We write about what matters to people who actually work with peptides: which compounds have real evidence behind them, which vendors can be trusted, what the FDA is doing and why it matters, and how to evaluate quality claims critically. Every article is grounded in published research, regulatory filings, and verifiable data.
Compound Reviews
Evidence-based breakdowns of what the published research actually shows for each compound.
Vendor Evaluations
Independent assessments with transparent methodology. We do not accept payment for reviews.
Regulatory Analysis
What the FDA is doing, what it means, and how it affects the research market.
Our coverage also includes analytical chemistry explainers and practical guides for researchers navigating a complicated and rapidly changing market.
Our Editorial Standards
We cite primary sources. When we reference a study, we link to it on PubMed. When we describe an FDA action, we link to the document. When we evaluate a vendor, we describe the methodology and evidence behind our assessment. We do not publish sponsored content, and vendor relationships do not influence our editorial judgments.
Corrections Policy
We get things wrong sometimes. When we do, we correct the record visibly and promptly. If you spot an error in any PeptideQuill article, contact us and we will investigate.
Why This Exists
The research peptide market lost its most trusted vendor in 2026. In the same period, the FDA raided one major vendor, secured guilty pleas from another’s founders, and reclassified several popular compounds. Researchers are making purchasing decisions worth hundreds or thousands of dollars with less reliable information than ever.
PeptideQuill was created to fill that gap — not with marketing, but with reporting. We believe informed researchers make better decisions, and better decisions lead to better research.
Contact
Questions, corrections, tips, or feedback: [email protected]